14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
ABAT vs EHTH: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, eHealth, Inc. (EHTH) is the stronger overall head-to-head candidate over American Battery Technology Company (ABAT) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). ABAT carries a Unified Composite Score of 43.9/100 (HOLD) at $0.96 (37.7x Forward P/E, -353.4% operating margin), whereas EHTH carries 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin).
Composite vs. Pillar Nuance: While ABAT currently prints a higher short-term Unified Composite Score (43.9/100 HOLD vs. EHTH 40.8/100 SELL), EHTH captures the overall institutional head-to-head verdict (5–4 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (11.9% vs. -353.4% operating margin) and revenue trajectory (-60.5% vs. +82.7% YoY).
Technical & Structure Timing Caution: ABAT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 28.2); meanwhile EHTH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABAT vs EHTH. Trailing 12-month operating profitability (ABAT -353.4% vs EHTH 11.9%) and valuation multiples (ABAT 37.7x vs EHTH 0.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance Brokers value chain with $13.4M market capitalization and 11.9% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ABAT vs EHTH Key Questions & Quantitative Answers
As of Nov 17, 2026, eHealth, Inc. (EHTH) is the stronger overall head-to-head candidate over American Battery Technology Company (ABAT) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). ABAT carries a Unified Composite Score of 43.9/100 (HOLD) at $0.96 (37.7x Forward P/E, -353.4% operating margin), whereas EHTH carries 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin). Composite vs. Pillar Nuance: While ABAT currently prints a higher short-term Unified Composite Score (43.9/100 HOLD vs. EHTH 40.8/100 SELL), EHTH captures the overall institutional head-to-head verdict (5–4 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (11.9% vs. -353.4% operating margin) and revenue trajectory (-60.5% vs. +82.7% YoY). Technical & Structure Timing Caution: ABAT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 28.2); meanwhile EHTH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ABAT leads the Growth & Scale pillar: ABAT posts +82.7% YoY revenue growth and +0.0% YoY earnings growth on $23M TTM revenue (-14.3% gross margin, -353.4% operating margin), compared with EHTH at -60.5% YoY revenue growth and -17.6% YoY earnings growth on $469M TTM revenue (100.0% gross margin, 11.9% operating margin). On trailing 12-month operating scale, ABAT generates $23M in USD-normalized revenue versus $469M for EHTH. In operating R&D and SG&A reinvestment, ABAT deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for EHTH.
EHTH screens cheaper on headline valuation multiples. ABAT trades at 37.7x Forward P/E, 37.7x Trailing P/E, N/M PEG, and 5.0x EV/Revenue (unreported FCF margin), whereas EHTH trades at 0.2x Forward P/E, 0.2x Trailing P/E, 0.72x PEG, and N/M EV/Revenue (12.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABAT (-72.8% ROE) versus EHTH (2.6% ROE) capital efficiency.
In options market volatility and institutional positioning, ABAT carries 91.2% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.14x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.43β · 109% Vol realized risk). By comparison, EHTH carries 128.7% implied volatility (56th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.61β · 117% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.